Neogenomics Inc (NASDAQ:NEO)

Delayed Data
As of Mar 21
 +0.09 / +1.10%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 10.00. The median estimate represents a +32.69% increase from the last price of 8.29.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 25

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -14.28%
Growthannually 32.48%


Growthquarterly -1.01%
Growthannually 2.83%
Key to the earnings and sales forecast charts.